Functional experiments confirmed that TRIP13 contributes to ccRCC malignancy by enhancing tumor proliferation (via Ki67 and PCNA), promoting migration and invasion, and facilitating immune escape. Here, TRIP13 is linked to nonpapillary renal cell carcinoma.